Acheteur pour une société CDMO d'API génériques en Europe

Entreprise recherchée

• Taille : Entreprise de taille moyenne
• Revenue: 3 -30 million EUR
• Lieu cible : Europe
• CFIE PHB262

Overview of buyer for generic API CDMO company in Europe

The company is a global, science-led pharmaceutical organization with over five decades of experience. In particular, in the pharmaceutical, chemical, and healthcare industries. Currently, it seeks to expand its presence through the acquisition of a generic API CDMO in Europe.

At this time, the organization has established itself as a significant player in the global pharmaceutical and healthcare arena. Over several decades, it has developed a strong reputation for its expertise in the development, scale-up, and commercialization of pharmaceutical products. Chiefly, the company’s focus is on becoming the integrated growth partner of choice for businesses worldwide.

Profile of buyer for generic API CDMO company in Europe

With a longstanding commitment to quality, integrity, leadership, respect, and sustainability, this organization has built extensive relationships with customers globally. Crucially, its capabilities in process chemistry, engineering, and manufacturing have enabled it to evolve as a strategic partner. Especially, involving collaboration, development, and manufacturing advanced pharmaceutical intermediates and APIs.

Activity and products of buyer for generic API CDMO company in Europe

Overall, the company is recognized as a key player in the production of artificial sweeteners, particularly saccharin, and contrast media intermediates. Further, it has also expanded its operations to include contract development and manufacturing, focusing on niche advanced intermediates and APIs. Essentially, the company applies cutting-edge processes to products at all phases. Thus, ensuring a robust and customized approach to meet customer needs.

Highlights of buyer for generic API CDMO company in Europe

• Expérience : Over 50 years of industry expertise
• Une portée mondiale : Operations in more than 50 countries, serving 140+ customers
• Manufacturing facilities: Four state-of-the-art facilities dedicated to innovation and quality
• Sustainability commitment: Aligned with the United Nations’ Sustainability Goals, the company is dedicated to green chemistry, pollution minimization, and carbon emission reduction

Altogether, this organization’s strategic growth plan includes new projects, products, and technologies, Moreover, it includes making strategic acquisitions and investments, particularly in the European market.

Plus d'informations : Acheteur pour une société CDMO d'API génériques en Europe

N'hésitez pas à nous contacter si vous souhaitez en savoir plus au sujet de cette Acheteur pour une société CDMO d'API génériques en Europe. Pour plus d'entreprises pharmaceutiques à vendre, veuillez consulter la section entreprises pharmaceutiques à vendre. Pour les autres acheteurs de produits pharmaceutiques, veuillez consulter la rubrique entreprises pharmaceutiques recherchées. Si vous êtes intéressé par les entreprises pharmaceutiques à vendre, veuillez visiter la page entreprises pharmaceutiques à vendre . Pour d'autres acheteurs d'entreprises pharmaceutiques, veuillez consulter la section entreprises pharmaceutiques recherchées.